Encouraging clinical progress for Huntington’s disease — a reminder of how rapidly new therapeutic modalities are advancing. Every success story like this strengthens the case for innovative approaches to treating some of the toughest genetic diseases. https://lnkd.in/e2f-qgVJ https://lnkd.in/e3hxzzi4
Pencil Biosciences Limited
Biotechnology Research
Alderley Park, United Kingdom 1,949 followers
Developing the Next Generation Gene Editing Technology
About us
Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases.
- Website
-
http://pencilbiosciences.com/
External link for Pencil Biosciences Limited
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Alderley Park, United Kingdom
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Genome Engineering, Research and Development, and Gene Editing
Locations
-
Primary
Get directions
Alderley Park, United Kingdom SK10 4TG, GB
Employees at Pencil Biosciences Limited
Updates
-
FDA clearance for gene-edited pig kidney trials is a landmark moment — not only for patients in need of transplants but for the entire field of genome editing. It opens the door to new opportunities where advanced editing technologies can directly address critical human health challenges. https://lnkd.in/exBSgzTm
-
We are excited to welcome Jonathan Thon, PhD, as Chair of our Board of Directors. Jonathan’s extensive experience in biotech entrepreneurship and scientific leadership will help guide Pencil as we advance our synthetic, Break Free gene editing platform toward new therapeutic possibilities and patient impact https://lnkd.in/e2bFSwQV
-
Exciting breakthrough in the fields of diabetes and gene editing Gene-edited allogeneic hypo-immune islet cells were transplanted into a patient with Type-I diabetes. The study reports that glucose-responsive insulin secretion was measured with no immune response against the gene edited cells detected. https://lnkd.in/etJhYCBr
-
We're #hiring a Bioinformatics Scientist at Pencil! This is great opportunity to work with a small team at a seed-stage startup working on developing new gene editing technology.